Special considerations in treating the elderly patient with epilepsy.
about
Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderlyRole of oxidative stress in epileptic seizures.Seizures and epilepsy in elderly patients of an urban area of Iran: clinical manifestation, differential diagnosis, etiology, and epilepsy subtypes.Review of topiramate for the treatment of epilepsy in elderly patients.The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments.Seizure Outcomes and Predictors of Recurrent Post-Stroke Seizure: A Retrospective Observational Cohort Study.Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries.Seizures and strokes for certain folks.Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.Optimizing antiepileptic drug therapy in the elderly.Neuroimaging observations in a cohort of elderly manifesting with new onset seizures: Experience from a university hospital.Age-accelerated psychomotor slowing in temporal lobe epilepsy.Psychosocial Impact of Epilepsy in Older Adults.Epilepsy and dementia in the elderly.Management of epilepsy in the elderly.Treatment and management of epilepsy in the elderly demented patient.Seizures in the elderly: impact on mental status, mood, and sleep.Management of new-onset epilepsy in the elderly.Epilepsy in the elderly: Special considerations and challenges.Epilepsy in the elderly: facts and challenges.Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.Seizures in the acute stroke setting.New onset epilepsy in the elderly: clinical, radiological and electroencephalographic features and treatment responses.Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly.What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new-onset epilepsy?Treating patients with medically resistant epilepsy.How important is Alzheimer's disease as a risk factor for unprovoked seizures and epilepsy in the elderly?Efficacy of phenytoin, valproic acid, carbamazepine and new antiepileptic drugs on control of late-onset post-stroke epilepsy in Taiwan.Management of provoked seizure.Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors.Safety and tolerability of zonisamide in elderly patients with epilepsy.Migraine, stroke and epilepsy: underlying and interrelated causes, diagnosis and treatment.Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.New-onset epilepsy risk factors in older veterans.[Seizures and epilepsies after stroke].Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.Epilepsy with onset at over 50 years of age: clinical and electroencephalographic characteristics.Indicators for elevated risk factors for alcohol-withdrawal seizures: an analysis using a random forest algorithm.The impact of epilepsy on health status among younger and older adults.Treatment of Epilepsy in the Elderly.
P2860
Q28397308-8C7DA6D8-2A87-45CE-A872-37D1A8433D1FQ30456096-BA1E8FC7-7075-412A-BBAC-A4123129E524Q33162149-7A13C449-BF18-45EA-B81E-9642E06B4B11Q33819386-F0CFCEA3-DA01-415C-B342-2583C990ED0EQ34998063-5F839A0A-2009-40AB-AC84-EF31661501EBQ35756186-780D4F5B-58BA-4C6F-9226-092EE5F1F9E1Q35758648-8239791D-DD72-4BB6-8291-DC8391BA7478Q36008891-98A080CE-5E97-4ECD-9A9D-D17C3EF3577EQ36110554-E994270B-B53C-4D0E-84FB-BCA55437DAB3Q36270316-79CF0B90-DB61-4A24-A43F-69A710E52CCEQ36543356-6EA3324F-F949-4960-A4CB-844ECCE64A69Q36586315-04F07319-7815-42F7-AB1B-3C910DF0CF5BQ37069614-0AFB3DB3-7DC1-4A80-A6A3-17BBCEBE981AQ37098571-98EA3088-8633-4301-B55A-928774CDB1D3Q37129785-BB750ECD-1327-482D-9ECE-6D5C4752CFB6Q37178698-3AE4A1FC-1D3E-4038-B924-7587DFE67A80Q37226443-41780A0A-8ABE-4985-8C4D-348F5BDCF4D1Q37541640-4FF40ED2-9750-4E4E-A0D1-3C9E3846D257Q37725946-47D4630E-307F-41F6-BBB2-179A23425CA7Q37818528-57819337-BBCD-4FA5-A4C8-50440D1E5B4DQ37969129-3BE61E72-C94D-4D6F-84EA-CDE7485E5793Q38196953-FB9A0430-0CAD-428B-BF7E-EB5AFA2D0D2AQ38833503-718A6BEE-82EF-4B1C-AE3C-52E5942C4366Q38835688-0FDC0737-4B5C-4EDB-BD81-A9B553887740Q38972913-E0759C00-DF2C-4403-B1F2-0A0C41D416B2Q39472516-59EB81ED-C018-42EC-9F3C-D4CD1EF98BD4Q39553637-8D1ECA08-C5B6-4E26-A0E7-6DE3E1CA03B3Q40764900-B4760B57-A351-44E3-A824-EA395B6589DEQ41851712-7F4D0057-0E45-4F6E-90D7-8B6F175F4F8EQ42624033-E8670343-F90C-4A9E-9251-2FB0E28EECB2Q44037728-6F817E01-494E-491F-9713-01C902F48520Q44131473-5BE16A09-746B-45DE-9BE2-30AE85437035Q44168300-337FB412-218B-428A-93E7-5680471A3617Q44354255-47E54792-F4EA-45A3-B15D-D349BF9BAAC2Q46072279-CB99590F-7649-44DA-8167-B637A3F93B04Q46216694-0C34E210-03DE-41C5-A495-F091A6DCB76BQ48339328-7B9D5911-08C8-4F68-82BC-C5916CB0DBE6Q51364455-A28B4DC6-4074-40BA-8C6E-81E6FC6FD14CQ51923981-343B0149-12EC-4517-A4A5-E0676A18510DQ52924534-64DE6A1B-39D4-4874-BFB0-24129E21B668
P2860
Special considerations in treating the elderly patient with epilepsy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Special considerations in treating the elderly patient with epilepsy.
@ast
Special considerations in treating the elderly patient with epilepsy.
@en
type
label
Special considerations in treating the elderly patient with epilepsy.
@ast
Special considerations in treating the elderly patient with epilepsy.
@en
prefLabel
Special considerations in treating the elderly patient with epilepsy.
@ast
Special considerations in treating the elderly patient with epilepsy.
@en
P2093
P1433
P1476
Special considerations in treating the elderly patient with epilepsy.
@en
P2093
A James Rowan
Flavia M Pryor
R Eugene Ramsay
P356
10.1212/WNL.62.5_SUPPL_2.S24
P407
P433
P577
2004-03-01T00:00:00Z